Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Ambu A/S: Extraordinary share option programme for the Executive Board related to the Big Five Strategy towards 2020

Ambu A/S
Posted on: 22 Dec 17

In accordance with the 'Overall guidelines for an incentive programme for the board of directors and executive board of Ambu A/S', the Board of Directors has decided to introduce a share option programme of up to 340,197 B-shares for the Executive Board (corresponding to 0.68% of the share capital), based on a price of DKK 2.5 each.

 

Contact
Lars Marcher, President & CEO, tel. +45 5136 2490, email: lm@ambu.com

Ambu A/S
Baltorpbakken 13
DK-2750 Ballerup
Tel. +45 7225 2000 
CVR no.: 63 64 49 19
www.ambu.com

Company Announcement no 12 2017_18


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Ambu A/S via GlobeNewswire
HUG#2158154
GlobeNewswire
globenewswire.com

Last updated on: 23/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.